Document Detail


Inherited thrombophilia and pregnancy complications revisited.
MedLine Citation:
PMID:  18669729     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inherited thrombophilias are not yet established as a cause of placenta-mediated pregnancy complications, such as fetal growth restriction, preeclampsia, abruption, and pregnancy loss. An inherited thrombophilia is only one of many factors that lead to development of these diseases and is unlikely to be the unique factor that should drive management in subsequent pregnancies. The paucity of evidence for benefit, coupled with a small potential for harm, suggests that low molecular weight heparin should be considered an experimental drug for these indications until data from controlled trials are published. At present, women with a history of placenta-mediated pregnancy complications, with or without a thrombophilia, should be followed closely without routine prophylactic low molecular weight heparin other than for prevention of venous thromboembolism in limited circumstances.
Authors:
Marc A Rodger; Michael Paidas; Claire McLintock; McLintock Claire; Saskia Middeldorp; Susan Kahn; Ida Martinelli; William Hague; Karen Rosene Montella; Ian Greer
Related Documents :
24075069 - Design of a flexible fetoscopy manipulation system for congenital diaphragmatic hernia.
21727159 - Stillbirth and neonatal mortality in monochorionic and dichorionic twins: a population-...
8846559 - Thrombosis and embolism.
6879389 - Warfarin therapy--a practical guide.
8671209 - Internal jugular vein thrombosis caused by resistance to activated protein c as a compl...
16004169 - Antiphospholipid syndrome: review.
11146079 - Treatment guidelines for depression in pregnancy.
10710739 - Fetal heart rate baselines in twins. interobserver agreement in antepartum estimation.
724179 - Ovarian pregnancy associated with copper-7 intrauterine device.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  112     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-01     Completed Date:  2008-09-16     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  320-4     Citation Subset:  AIM; IM    
Affiliation:
Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. mrodger@ohri.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / physiopathology
Female
Heparin / therapeutic use
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Placenta / physiopathology*
Placental Circulation / physiology*
Pregnancy
Pregnancy Complications, Hematologic / physiopathology*
Thrombophilia / physiopathology*
Chemical
Reg. No./Substance:
0/Heparin, Low-Molecular-Weight; 9005-49-6/Heparin
Comments/Corrections
Erratum In:
Obstet Gynecol. 2008 Dec;112(6):1392
Note: Claire, McLintock [corrected to McLintock, Claire]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sex-related knowledge, attitudes, and behaviors of U.S. medical students.
Next Document:  Home uterine activity monitoring: the role of medical evidence.